Action
EGFR
Approval Jurisdiction
2006 FDA 2007 EMA
Approved for clinical use
EGFR colorectal cancer
CAS
339177-26-3
Commercial Vendor
Amgen
Compound Image
Panitumumab.png
Compound name
Panitumumab
Reference
Reference 2
Approved Drug List
1